References
- FultzNBurgioKDioknoAKinchenKOdenchainRBumpRBurden of stress urinary incontinence for community dwelling womenAm J Obstet Gynecol20031891275128214634553
- RogersGVillarrealAKammerer-DoakDQuallsCSexual function in women with and without urinary incontinence and/or pelvic organ prolapseInt Urogynecol J Pelvic Floor Dysfunct20011236136511795636
- AbramsPCardozoLFallMThe standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence SocietyUrology200361374912559262
- HunskaarSLoseGSykesDVossSThe prevalence of urinary incontinence in women in four European countriesBJU Int20049332433014764130
- SubakLBrownJKrausSThe “costs” of urinary incontinence for womenObstet Gynecol200610790891616582131
- WardKHiltonPUK and Ireland TVT Trial Group. Tension free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5 year follow upBJOG200811522623317970791
- MelvilleJDelaneyKNewtonKKatonWIncontinence severity and major depression in incontinent womenObstet Gynecol200510658559216135592
- FieldsHHeinricherMMasonPNeurotransmitters in nociceptive modulatory circuitsAnnu Rev Neurosci1991142192451674413
- RenKDubnerRDescending modulation in persistent pain: an updatePain20021001612435453
- StahlSBasic psychopharmacology of antidepressants, part I: antidepressants have seven distinct mechanisms of actionJ Clin Psychiatry199859suppl 45149554316
- DetkeMLuYGoldsteinDDuloxetine 60 mg once daily for major depressive disorder: a randomised double-blind placebo controlled trialJ Clin Psychiatry20026330831512000204
- GoldsteinDMallinckrodtCLuYDemitrackMDuloxetine in the treatment of major depressive disorder: a double blind clinical trialJ Clin Psychiatry20026322523111926722
- RaskinJGoldsteinDMallinckrodtCFergusonMDuloxetine in the long term treatment of major depressive disorderJ Clin Psychiatry2003641237124414658974
- RaskinJPritchettYWangFA double blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic painPain Med2005634635616266355
- PajonciniCConstantiniFGuerciniFBiniVPorenaMClinical and urodynamic features of intrinsic sphincter deficiencyNeurourol Urodyn20032226426812808699
- FleischmannNFlisserABlaivasJPanagopoulosGSphincteric urinary incontinence: relationship of vesical leak point pressure, urethral mobility and severity of incontinenceJ Urol2003169999100212576830
- PierceLReyesMThorKInnervation of the levator ani muscles in the female squirrel monkeyAm J Obstet Gynecol20031881141114712748458
- BarberMBremerRThorKDolberPKuehlTCoatesKInnervation of the female levator ani musclesAm J Obstet Gynecol2002187647112114890
- MichelMPetersSRole of serotonin and noradrenaline in stress urinary incontinenceBJU Int200494Suppl 1233015139860
- EspeyMDownieJSerotonergic modulation of cat bladder function before and after spinal transectionEur J Pharmacol19952211671171360901
- ThorKKatofiascMEffects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anaesthetized female catJ Pharmacol Exp Ther1995274101410247636716
- BoySReitzAWirthBKarsentyGKnappPSchurchBFacilitatory neuromodulative effect of duloxetine on urethral sphincter motor neurones in healthy femalesEur Urol Suppl20054253 Abstract 998.
- BumpRBensonJBrubakerLBiomechanical and electrophysiological effects of duloxetine in women with stress urinary incontinenceNeurourol Urodyn200423 abstract 269.
- AthanasiouSChalihaCDigesuAThe effects of duloxetine on urethral function and sphincter morphologyInt Urogynecol J Pelvic Floor Dysfunct20071876376717061027
- DuckettJPatilAAggarwalIThe effect of duloxetine on urethral sphincter morphologyUltrasound Obstet Gynecol20083120620918254135
- NortonPZinnerNYalcinIBumpRfor the Duloxetine Urinary Incontinence Study GroupDuloxetine versus placebo in the treatment of stress urinary incontinenceAm J Obstet Gynecol2002187404812114886
- DmochowskiRMiklosJNortonPZinnerNYalcinIBumpRfor the Duloxetine Urinary Incontinence Study GroupDuloxetine versus placebo for the treatment of North American women with stress urinary incontinenceJ Urol20031701259126314501737
- van KerrebroeckPAbramsPLangeRfor the Duloxetine Urinary Incontinence Study GroupDuloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinenceBJOG200411124925714961887
- MillardRMooreKRenckenRYalcinIBumpRfor the Duloxetine Urinary Incontinence Study GroupDuloxetine versus placebo in the treatment of stress urinary incontinence: a four continent randomized clinical trialBJU Int20049331131814764128
- GhoniemGSchagen van LeeuwenJElserDA randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinenceJ Urol20051731647165315821528
- PerucchiniDDeLanceyJAshton-MillerJGaleckiAScheerGAge effects on urethral striated muscle II: anatomic location of muscle lossAm J Obstet Gynecol200218635636011904591
- ViktrupLYalcinIDuloxetine treatment of stress urinary incontinence in women: effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacyEur J Obstet Gynecol Reprod Biol200713310511316769171
- Schagen van LeeuwenJLangeRJonassonAChenWViktrupLEfficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinenceMaturitas20086013814718547757
- DuckettJVellaMKavakuntlaGBasuMTolerability and efficacy of duloxetine in a non-trial situationBJOG200711454354717355360
- CardozoLDrutzHBayganiSBumpRPharmacological treatment of women awaiting surgery for stress incontinenceObstet Gynecol200410451151915339761
- VellaMDuckettJBasuMDuloxetine one year on: the long term outcome of a cohort of women prescribed duloxetineInt Urogynecol J Pelvic Floor Dysfunct20081996196418231697
- SteersWHerschornSKrederKDuloxetine OAB Study Group. Duloxetine compared with placebo for treating women with symptoms of overactive bladderBJU Int200710033734517511767
- BentAGousseAHendrixSDuloxetine compared with placebo for the treatment of women with mixed urinary incontinenceNeurourol Urodyn20082721222117580357
- BaeJMoonDLeeJThe effects of a selective noradrenaline reuptake inhibitor on the urethra: an in vitro and in vivo studyBJU Int20018877177511890252
- ErdincAGuratesBCelikHPolatAKumruSSinsekMThe efficacy of venlafaxine in treatment of women with stress urinary incontinenceArch Gynecol Obstet2008 Jul 16. Epub ahead of print.
- National Collaborating Centre for Women’s and Children’s HealthNICE Clinical Guideline Number 40: The management of urinary incontinence in womenNational Institute for Health and Clinical Excellence2006London
- Castro-DiazDPalmaPBouchardCDuloxetine Dose Escalation Study GroupEffect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinenceInt Urogynecol J Pelvic Floor Dysfunct20071891992917160693
- RobinsonDAndersKCardozoLWhat do women want: interpretation of the concept of cureJ Pelvic Med Surg20039273277